BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17386852)

  • 1. Nitric oxide and cardiac remodeling.
    Passeri J; Bloch KD
    Heart Fail Clin; 2005 Jul; 1(2):275-86. PubMed ID: 17386852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nitric oxide and heart failure].
    Yoshioka T; Takahashi M; Ikeda U
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physical activity and nitric oxide].
    Tanaka H; Mori S; Nagaya R
    Nihon Rinsho; 2000 Sep; 58 Suppl():63-6. PubMed ID: 11085090
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms.
    Manoury B; Montiel V; Balligand JL
    Cardiovasc Res; 2012 May; 94(2):304-15. PubMed ID: 22227153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart.
    Prabhu SD
    Circ Res; 2004 May; 94(9):1155-7. PubMed ID: 15142968
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory role of nitric oxide in cardiac performance.
    Smiljić S; Nestorović V; Savić S
    Med Pregl; 2014; 67(9-10):345-52. PubMed ID: 25546983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide for clinicians.
    Krishnaswami S
    J Assoc Physicians India; 2001 Jun; 49():634-8. PubMed ID: 11584940
    [No Abstract]   [Full Text] [Related]  

  • 10. Iptakalim: a new or just another KCO?
    Costa AD
    Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of nitric oxide in the pathophysiology of heart failure.
    Champion HC; Skaf MW; Hare JM
    Heart Fail Rev; 2003 Jan; 8(1):35-46. PubMed ID: 12652158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO and cardiac diastolic function.
    Paulus WJ; Shah AM
    Cardiovasc Res; 1999 Aug; 43(3):595-606. PubMed ID: 10690331
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute heart failure as "acute endothelitis"--Interaction of fluid overload and endothelial dysfunction.
    Colombo PC; Onat D; Sabbah HN
    Eur J Heart Fail; 2008 Feb; 10(2):170-5. PubMed ID: 18279772
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting arterial chemoreceptor over-activity in heart failure with a gas.
    Paterson DJ
    Circ Res; 2005 Aug; 97(3):201-3. PubMed ID: 16081873
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelial dysfunction and heart failure.
    Ferrari R; Bachetti T
    Ital Heart J; 2001 Sep; 2 Suppl 3():45S-47S. PubMed ID: 11593933
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitric oxide and cardiac function.
    Rastaldo R; Pagliaro P; Cappello S; Penna C; Mancardi D; Westerhof N; Losano G
    Life Sci; 2007 Aug; 81(10):779-93. PubMed ID: 17707439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: ion channel remodeling in the failing ventricle.
    Nass RD; Aiba T; Tomaselli GF; Akar FG
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis.
    Wollert KC; Drexler H
    Heart Fail Rev; 2002 Oct; 7(4):317-25. PubMed ID: 12379817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure].
    Gan RT; Li WM; Wang X; Wu S; Kong YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):675-8. PubMed ID: 17996136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.